Related Experiment Video
Updated: Jun 5, 2026

08:49
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Study on the interactions between ginsenosides and lysozyme under acidic condition by ESI-MS and molecular docking
Chenling Qu1, Songcheng Yu, Aixi Bai
1College of Grain Oil and Food Science, Henan University of Technology, 140 Songshan South Road, Zhengzhou 450052, China. quchenling@gmail.com
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
|December 25, 2010
Summary
Ginsenosides Rg1 and Re interact with lysozyme, forming stable complexes. Their stability varies with acidity and binding ratio, offering insights into drug interactions.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular interactions
Background:
- Ginsenosides are key compounds in traditional medicine.
- Lysozyme is a crucial enzyme in the immune system.
- Understanding ginsenoside-protein interactions is vital for drug development.
Purpose of the Study:
- To investigate the noncovalent interactions between ginsenosides (Rg1, Re) and lysozyme.
- To compare the binding affinities and stabilities of different ginsenoside-lysozyme complexes.
- To elucidate the influence of pH on these molecular interactions.
Main Methods:
- Electrospray ionization mass spectrometry (ESI-MS) for complex detection and quantification.
- Molecular docking simulations to predict binding sites and interactions.
- Calculation of dissociation constants from mass spectra peak intensities.
Main Results:
- 1:1 and 2:1 noncovalent complexes of ginsenosides and lysozyme were identified.
- Ginsenoside Rg1 formed a more stable 1:1 complex with lysozyme than ginsenoside Re.
- Complex stability decreased with increasing acidity, with notable differences in 2:1 complex behavior.
Conclusions:
- Ginsenosides Rg1 and Re bind to the active sites of lysozyme.
- Acidity-induced conformational changes in lysozyme affect complex stability.
- Findings provide a basis for understanding ginsenoside efficacy and developing related therapeutics.
